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Background: Laparoscopic cholecystectomy (LC) has become the treatment of choice for gallbladder lesions, but it
is not a pain-free procedure. This study explored the pain relief provided by combined wound and intraperitoneal
local anesthetic use for patients who are undergoing LC.
Methods: Two-hundred and twenty consecutive patients undergoing LC were categorized into 1 of the following
4 groups: local wound anesthetic after LC either with an intraperitoneal local anesthetic (W + P) (group 1) or
without an intraperitoneal local anesthetic (W + NP) (group 2), or no local wound anesthetic after LC either with
intraperitoneal local anesthetic (NW + P) (group 3) or without an intraperitoneal local anesthetic (NW + NP)
(group 4). A visual analog scale (VAS) was used to assess postoperative pain. The amount of analgesic used and the
duration of hospital stay were also recorded.
Results: The VAS was significantly lower immediately after LC for the W + P group than for the NW + NP group
(5 vs. 6; p = 0.012). Patients in the W + P group received a lower total amount of meperidine during their hospital
stay. They also had the shortest hospital stay after LC, compared to the patients in the other groups.
Conclusion: Combined wound and intraperitoneal local anesthetic use after LC significantly decreased the
immediate postoperative pain and may explain the reduced use of meperidine and earlier discharge of patients so
treated.Background
Since 1987, laparoscopic cholecystectomy (LC) has be-
come the standard procedure for the treatment of gall-
bladder lesions. Increased experience with this technique
has altered some of the previous contraindications for LC
such as patients with end-stage renal disease, liver cirrho-
sis, and severe cardiovascular disease [1-3]. A major bene-
fit of using laparoscopy for upper gastrointestinal surgery
is that it avoids an upper abdominal incision. Such inci-
sions hinder postoperative pulmonary rehabilitation, cause
surgical wound pain, and increase the total medical cost
[4-6]. Laparoscopic cholecystectomy is the treatment of
choice for a wide spectrum of gallbladder diseases [7-10].* Correspondence: yehchunnan@gmail.com
†Equal contributors
1Department of Surgery, Chang Gung Memorial Hospital, Chang Gung
University, 5, Fu-Hsing Street, Kwei-Shan, Taoyuan, Taiwan
Full list of author information is available at the end of the article
© 2014 Yeh et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.However, many investigators continue to work to improve
postoperative pain control and improve the quality of hos-
pital stays. Many methods have been proposed to improve
pain control such as the use of local anesthetics at the tro-
car site [11,12], intraperitoneal injection of local anes-
thetics [13-15], decreasing pneumoperitoneum pressure
[16-18], and decreasing the number of operative ports
[19,20]. The relief of pain resulting from combined wound
and intraperitoneal local anesthetics for patients under-
going LC has been evaluated [21]; however, the treatment
still needs a full evaluation because of a limited number of
patients and inappropriate use of intraperitoneal local
anesthetics in the previous study [21]. In this prospective
case-controlled study, we clarified the impact of combined
wound and intraperitoneal local anesthetic use on pain re-
lief in patients who underwent LC.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Between 2009 and 2011, 220 consecutive patients who
underwent LC (performed by author C. N. Yeh) at the
Department of Surgery in the Chang Gung Memorial
Hospital (Taoyung, Taiwan) were included in this pro-
spective case-controlled study. The study participants
were adult patients who had been referred for elective LC
to treat gallbladder lesions. The study was approved by
the local institutional review board of the Chang Gung
Memorial Hospital (No. 95-0147B). Patients provided
written, informed consent authorizing group allocation
and use of anesthetics for pain relief.
Allocation of the patients
Each of the consecutive 220 patients was liberally rather
than randomly allocated into 1 of 4 groups. The groups
included patients who received a local wound anesthetic
at the end of LC either with an intraperitoneal local
anesthetic (W + P group; n = 55) or without an intra-
peritoneal local anesthetic (W +NP group; n = 55) and
patients who received no local wound anesthetic at the
end of LC either with an intraperitoneal local anesthetic
(NW+ P group; n = 55) or without an intraperitoneal
local anesthetic (NW+NP; n = 55) (Figure 1). The diag-
nostic workup for all patients before LC included a
medical history, physical examination, and abdominal ultra-
sonography. Abdominal computed tomography and/or
magnetic resonance cholangiopancreatography might be
needed if concurrent biliary tract stone was suspected
clinically. Eligible patients had planned LC surgery; had ad-
equate hematological, hepatic, and renal functions; were
20–85 years old; were not pregnant; and provided informed
consent. Patients were excluded if they had taken immuno-
suppressive drug therapy within previous 6 months; had anFigure 1 Algorithm of the group allocation for 220 patients
undergoing laparoscopic cholecystectomy. LC = laparoscopic
cholecystectomy; NW + NP = no wound anesthetic and no
intraperitoneal anesthetic use; NW + P = no wound anesthetic but
intraperitoneal anesthetic use; W + NP =wound anesthetic but no
anesthetic use; W + P = wound anesthetic and intraperitoneal
anesthetic use.immunosuppressive condition such as acquired immu-
nodeficiency syndrome, autoimmune disorders, organ
transplantation, and radiation therapy; had undergone
chemotherapy within the previous 6 months; or had
insulin-dependent diabetes mellitus (i.e., type 1 diabetes).
Discharge from the hospital was the primary endpoint.
Between the groups, we compared the clinical features,
laboratory data, operative outcomes, pain score, and the
amount of analgesic required. The hospital stay was de-
fined as the number of days between the operation and
the actual date of hospital discharge. Surgical mortality
was defined as death occurring within 1 month of surgery.
LC protocol
One author (C. C. Lin), an anesthesiologist, administered
general anesthesia to all 220 patients by using the same
protocol. Before the start of the cholecystectomy, the LC
patients in the W+ P group and in the NW+ P group re-
ceived 5 mg/kg of 1.0% levoropivacaine in 200 mL of 0.9%
normal saline as an intraperitoneal infusion into the op-
erative field (i.e., infusion after the saline loading test and
before carbon dioxide insufflation). Levoropivacaine was
administered in 2 separate 100-mL infusions while the pa-
tient lay in the Trendelenburg position. The first infusion
was administered in the right subdiaphragmatic region
and the second infusion was administered in the left
subdiaphragmatic region. Patients in the W+NP and
NW+NP groups received 200 mL of 0.9% normal saline
as the intraperitoneal infusion of the operative field before
the start of surgery. All infusion fluid was drained after
the completion of the LC. The LC patients in the W+ P
group and in the W+NP group received a total of 20 mL
of 1.0% levoropivacaine at the port sites immediately after
wound closure (6 mL at the epigastric port, 6 mL at the
umbilical port; and 4 mL at each working port). Patients
in the NW+P and NW+NP groups received a total of
20 mL of 0.9% normal saline at the port sites immediately
after wound closure (6 mL at the epigastric port, 6 mL at
the umbilical port; and 4 mL at each working port). At the
end of surgery, local anesthesia or normal saline was ap-
plied to the skin, subcutis, fascia, and parietal peritoneum
through the port sites.
Patient monitoring and testing
A visual analog scale (VAS) with a 10-cm vertical score
ranged from “no pain” to “worst possible pain”. The VAS
was used to assess postoperative pain when the patient
awoke in the operating room (approximately 1 h after sur-
gery), at 6 h after surgery, and at 24 h after surgery. The
pain score was recorded by 1 of 4 authors (Y. Y. Liu, S. Y.
Wang, C. Y. Tsai, or C. N. Yeh) who were blinded to the
patient groups. Acetaminophen was used for pain relief in
the postoperative period. Meperidine was further used as
rescue pain relief if acetaminophen did not work well.
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amount of analgesics used. Biochemical data, operative
time, hospital stay, and perioperative complications were
recorded.
Statistics
All data are presented as the percentage of patients or the
mean with the 95% confidence interval or median with
interquartile ranges. Numerical data were compared by
using analysis of variance (ANOVA) tests between groups.
The Scheffe’s test was used as the post hoc test for com-
paring between subgroups. Ordinal scale data were
compared with the Kruskal-Wallis test between groups
and a post hoc test was used for comparing between
subgroups. Pearson’s chi square tests and Fisher’s exact
tests were used for nominal variables. All statistical ana-
lyses were performed by SPSS software (version 10.00)
(SPSS, Chicago, IL). Values of p < 0.05 were considered
statistically significant.
Results
Clinical features, laboratory data, and operative outcomes
Tables 1 and 2 summarize the demographic data and cli-
nical features of the 4 groups of patients with gallbladder
lesions who underwent LC (Figure 1). All 4 groups had
similar age distribution and gender ratio. The 4 groups
displayed no significant difference in the ratio of patients
with previous abdominal operations and associated dis-
ease and patients without these factors. All 4 groups had
similar American Society of Anesthesia (ASA) grades, op-
eration times, and conversion rates. There was no 30-day
mortality in any group. No significant difference in labora-
tory data was noted when between-group comparisons
were performed.
Evaluation of pain intensity, analgesic requirement, and
duration of hospital stay
Table 2 shows the comparison of the assessed pain in-
tensity and analgesic requirements of the 4 study groups.Table 1 Demographic data of 220 patients who underwent la
wound anesthetic and with or without an intraperitoneal ane
NW+NP (N = 55) NW
Age (y) 51.1 ± 15.0 53
Gender (M:F) 24:31 26
Previous abdominal operation history (+) 11 (20) 11
Associated disease (+) 23 (41.8) 30
ASA grade (1:2:3) 18:33:4 14
Operation time (min) 84.9 ± 28.7 84
Hospital stay (d) 2.3 ± 2.1 2.1
ASA = American Society of Anesthesia; NW + NP = no wound anesthetic and no intra
anesthetic use; W+ NP = wound anesthetic but no intraperitoneal anesthetic use; W
The data are presented as the number (percentage) or as the mean ± the standard
*p < 0.05, based on results of the post hoc Scheffe test.All 4 patient groups experienced a gradual reduction in
pain after surgery, as evidenced by the pain VAS scores
and the need for analgesics. The patients in the NW+
NP group had higher VAS scores after LC, compared to
patients in the other 3 groups (p = 0.012). By contrast,
the VAS was significantly lower in the patients in the
W + P group than in the patients in the NW+NP group
(5 vs. 6; p < 0.05). The W + P group patients had the
lowest VAS scores and therefore required the least
amount of meperidine. The W + P group patients also
had the shortest hospital stay after LC (1.6 ± 1.0 days),
compared to 2.3 ± 2.1 days for the NW+NP group,
2.1 ± 1.0 days for the NW+ P group, and 2.0 ± 0.9 days
for the W +NP group (p = 0.039) (Figure 2).
Discussion
Because LC has become the treatment of choice for many
gallbladder diseases, postoperative analgesia for LC pain
has been evaluated in several prospective studies. Pain
after LC is less intense and lasts a shorter time, compared
to pain after open cholecystectomy [4-6]. This explains
why patients can be discharged within days of LC surgery
and can return to their normal daily activities more
quickly, compared to open cholecystectomy. However, LC
is not a pain-free procedure.
Postoperative pain control is directed at early mobi-
lization, recovery, and discharge. However, pain can play a
major role in metabolic and endocrine responses and can
impair postoperative pulmonary function. Various me-
thods have been proposed to control LC postoperative
pain such as the use of local anesthesia [15], intraperi-
toneal infiltration of local anesthesia [16], preoperative
administration of anti-inflammatory drugs [17], utilizing
carbon dioxide (CO2) at body temperature, applying intra-
pleural morphine [18], and the combined use of nonste-
roidal anti-inflammatory drug (NSAIDs) and opioids [19].
Several factors have been extensively studied that may
moderate pain after laparoscopic surgery such as the use
of local anesthesia at the incision sites, intraperitonealparoscopic cholecystectomy with or without a local
sthetic
+ P (N = 55) W + NP (N = 55) W + P (N = 55) p
.3 ± 16.3 50.8 ± 13.5 48.6 ± 14.2 0.505
:29 35:20 28:27 0.172
(20) 15 (27.3) 8 (14.5) 0.429
(54.5) 21 (38.1) 31 (56.4) 0.142
:33:8 28:24:3 17:34:4 0.089
.2 ± 22.6 82.4 ± 28.9 90.0 ± 24.1 0.535
± 1.0 2.0 ± 0.9 1.6 ± 1.0* 0.039
peritoneal anesthetic use; NW + P = no wound anesthetic but intraperitoneal
+ P = wound anesthetic and intraperitoneal anesthetic use.
deviation.
Table 2 Pain score and analgesic use of 220 patients who underwent laparoscopic cholecystectomy with or without a
local wound anesthetic and intraperitoneal anesthetic
NW+NP NW+ P W+NP W+ P p
Pain analog scale
1 h post LC 6 (4–8) 5 (3–8) 5 (3.7-6) 5 (3–6)a 0.012
6 h post-LC 4 (3–6) 4 (3–5) 4 (2–6) 4 (3–5) 0.330
24 h post-LC 2 (2–3) 2.5 (1–4) 2 (1–4) 2 (2–4) 0.974
Merperidine use (50 mg/pc)
24 h post-LC 35 (0–62.5) 0 (0–50) 25 (0–50) 0 (0–25)b 0.003
Total amount 40 (0–75) 50 (0–50) 35 (0–50) 0 (0–50) 0.500
Acetaminophen requirement (500 mg)
Total amount 500 (0–2000) 0 (0–625) 500 (0–1000) 0 (0–500) 0.064
LC = laparoscopic cholecystectomy; NW+ NP = no wound anesthetic and no intraperitoneal anesthetic use; NW+ P = no wound anesthetic but intraperitoneal
anesthetic use; W+ NP = wound anesthetic but no anesthetic use; W+ P =wound anesthetic and intraperitoneal anesthetic use.
ap < 0.05, compared to NW + NP group patients (based on the results of the post hoc Kruskal-Wallis test).
bp < 0.05, compared to NW + NP group patients (based on the analysis of variance [ANOVA] post hoc Scheffe’s test results).
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number of operative ports, application of pneumoperi-
toneum, and maintaining pneumoperitoneum pressure.
Several mechanisms of postlaparoscopic pain generation
have also been proposed such as ruptured blood vessels
resulting from the rapid distension of the peritoneum,
traumatic nerve traction, release of inflammatory mole-
cules, trauma to the abdominal wall, trauma occurringFigure 2 The duration of the hospital stay of the 4 groups of
patients [i.e., patients who received a local anesthetic at the end of
laparoscopic cholecystectomy either with an intraperitoneal local
anesthetic (W + P group; n = 55) or without an intraperitoneal
local anesthetic (W +NP group; n = 55), and patients who
received no local wound anesthetic at the end of LC either with
an intraperitoneal local anesthetic (NW+ P group; n = 55) or
without an intraperitoneal local anesthetic (NW+NP group;
n = 55)]. *p < 0.05. The W + P patients had significantly shorter
hospital stays than the NW + NP patients. All data are presented
as the mean with 95% confidence interval standard deviations.
NW+NP= no wound anesthetic and no intraperitoneal anesthetic use;
NW+ P = no wound anesthetic but intraperitoneal anesthetic use;
W +NP =wound anesthetic but no anesthetic use; W + P =wound
anesthetic and intraperitoneal anesthetic use.with the removal of the gallbladder from the abdomen,
pneumoperitoneum created by utilizing CO2, mainte-
nance of high abdominal pressure, irritation of the phrenic
nerve, and application of cold CO2 [14]. Because pain is
multifactorial, no consensus has been reached regarding
effective postoperative pain relief for patients who have
undergone LC [11]. A number of studies have been con-
ducted in an effort to reduce postoperative pain after this
surgery, but the results have varied.
Early studies focused primarily on gynecological pro-
cedures [22,23]. However, studies of pain management
that are specific to LC have recently been increasing.
Recommendations for the treatment of postoperative
pain in patients undergoing LC include NSAIDs, local
anesthesia injection at the incision sites, opioids, and
preoperative steroid use [24,25]. In a previous study
[12], we found that applying at the port sites local
anesthesia with a ropivacaine infusion at the end of LC
significantly decreased immediate postoperative pain.
This short-term benefit explains the patients’ reduced
need for parenteral analgesics after LC and the earlier
discharge of patients who received local anesthesia in-
fusions, compared to patients who did not have this
treatment.
Several trials assessing the use of intraperitoneal local
anesthetics have yielded conflicting results. The use of
intraperitoneal local anesthesia reduces shoulder tip
pain. Its value when used in combination with a local
anesthetic has been assessed previously [21]; however,
there were several drawbacks in that trial. First, the case
number in each arm of the trial may have been limited.
Second, the timing of the use of an intraperitoneal local
anesthetic was inappropriate because of the routine re-
commendation, based on a literature review and meta-
analysis, that an intraperitoneal local anesthetic be used
before LC [22,26].
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fits of combined local anesthetic (i.e., after LC) and intra-
peritoneal local anesthetic infusions (before LC) for
reducing LC postoperative pain. As demonstrated in this
study, LC is not a pain-free procedure. Pain remains a
prevalent complaint after LC during the early postopera-
tive period. This study clearly showed that pain peaks
within the first few hours after the operation, but dimi-
nishes greatly by the next day, as demonstrated by the dis-
tribution of pain scores and requirement for parenteral
analgesics. Incisional pain is reportedly more intense than
visceral pain and dominates during the first 48 hours
immediately following LC [13]. Therefore, combining the
use of analgesics on incisions and in the peritoneum
should provide the best pain control. This study confirms
our previous finding that routine LC without any local
anesthetic is associated with more pain than LC with a
local anesthetic. Combined local and intraperitoneal infil-
tration of levoropivacaine during surgery significantly re-
duced the immediate pain intensity, reduced the number
of patients who required postoperative parenteral analge-
sics, and reduced the duration of the hospital stay. The
combined administration of a local anesthetic and an in-
traperitoneal anesthetic in patients resulted in a longer
period between LC and the need for additional analgesics,
compared to patients who did not receive both measures.
Furthermore, patients who received combined local and
intraperitoneal infiltration of levoropivacaine during sur-
gery required significantly lower doses of analgesics, com-
pared to patients who did not have this treatment. This
finding is explained by the lower pain intensity expe-
rienced by patients who received the combined local and
intraperitoneal infiltration of an anesthetic.
Levoropivacaine is a new long-acting local anesthetic
that was developed after evidence of severe bupivacaine-
related toxicity emerged. Levoropivacaine contains only
the left-isomer of the active chemical, and based on its
three-dimensional structure, it has less toxic potential
for the central nervous system and heart [27]. Several
clinical studies have evaluated its toxicology and clinical
profile, but these differences do not appear to affect clin-
ical practice. The relatively low toxic potential of the
pure left-isomer supports its use in clinical situations in
which the risk of systemic toxicity from overdosing or
from unwanted intravascular injection is high (e.g., du-
ring an epidural or peripheral nerve block). Adverse
effects associated with the use of levoropivacaine for
local anesthesia—such as allergic reactions, local tissue
toxicity, cardiovascular system toxicity, central nervous
system toxicity, and systemic toxicity—are reportedly
rare [27]. We did not observe any such adverse effects in
our study.
Although our results may support the use of combined
wound and intraperitoneal anesthetics for LC patientssignificantly decreased immediate postoperative pain,
there are several limitations inherent in this study. First,
this was a prospective case controlled study, and the selec-
tion of patients would not be randomized. Although all of
the data were collected prospectively and the characte-
ristics of four groups were similar and homogeneous, the
selective and recall bias could not be prevented com-
pletely. Another obvious limitation of this study is that it
was not double-blinded. Hence, biases of the patient’s and
surgeon’s attitudes are likely to arise, especially for evalua-
tion of intensity of pain. The advantages of the combined
pain relief procedures observed in unblinded patients may
lead patients to be more motivated to see the benefit after
received “combined pain relief” procedure. Unblinded
surgeons may also contribute to the better postoperative
recovery as surgeons may take more aggressive attitudes
to early discharge after operation. To overcome these limi-
tations, our results should be confirmed by further pro-
spective randomized controlled trials.Conclusions
In conclusion, the use of combined wound and intraperi-
toneal anesthetics for LC patients significantly decreased
immediate postoperative pain. This short-term benefit
may explain the decreased use of immediate parenteral
analgesics and earlier discharge.
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